| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2184375C Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
| 05/02/2006 | CA2173974C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 04/27/2006 | WO2006044961A1 Ppar-gamma modulatores |
| 04/27/2006 | WO2006044869A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 04/27/2006 | WO2006044741A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| 04/27/2006 | WO2006044687A2 Kinase inhibitors |
| 04/27/2006 | WO2006044582A2 Use of baff to treat sepsis |
| 04/27/2006 | WO2006044527A1 Imidazole derivatives as vanilloid receptor ligands |
| 04/27/2006 | WO2006044454A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | WO2006044412A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | WO2006043891A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043615A1 Use of immunesuppressant receptor |
| 04/27/2006 | WO2006042479A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/27/2006 | WO2006042396A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | WO2006021660A8 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 04/27/2006 | WO2004105773A3 Use of s1p |
| 04/27/2006 | US20060089497 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 04/27/2006 | US20060089404 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 04/27/2006 | US20060089395 Nf-kb activation inhibitors |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089375 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 04/27/2006 | US20060089362 N-(2- piperazinophenyl) methyl 3-(3-chlorophenyl)-pyrazolo-[1,5-a]-pyrimidine-6-amide; treats circulatory diseases such as diseases due to inflammation, circulatory disorders, enhanced proliferation activities, and the like, i.e., hypertension, diabetes, diabetic complications, arteriosclerosis |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060089299 Selective treatment of endothelial somatostatin receptors |
| 04/27/2006 | US20060088932 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088529 Bispecific monoclonal antibodies to IL-12 and IL-18 |
| 04/27/2006 | US20060088514 Formulation comprising a bacterial strain |
| 04/27/2006 | DE102005049750A1 Immunological absorber for treating inflammations, comprises organic/synthetic polymer substrates, which is covalently bonded to poly/monoclonal antibodies are arranged against to the peptide complement factors and sepsis mediators |
| 04/27/2006 | CA2584655A1 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| 04/27/2006 | CA2584459A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584368A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/27/2006 | CA2583900A1 Use of baff to treat sepsis |
| 04/27/2006 | CA2583576A1 Chimera (double) decoy |
| 04/27/2006 | CA2583392A1 Imidazole derivatives as vanilloid receptor ligands |
| 04/27/2006 | CA2583267A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | CA2574518A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/26/2006 | EP1650312A2 Functional assay of high-density lipoprotein |
| 04/26/2006 | EP1650205A1 Cyclohexanecarboxylic acid compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1649856A2 Use of pimecrolimus for selective immunomodulation |
| 04/26/2006 | EP1648888A1 N-(heterobicycloalkanes)-substituted indoles or heteroderivatives thereof |
| 04/26/2006 | EP1648881A1 Substituted indole ligands for the orl-1 receptor |
| 04/26/2006 | EP1648879A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 04/26/2006 | EP1648878A1 Piperidine compounds and pharmaceutical compositions containing them |
| 04/26/2006 | EP1648871A1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 04/26/2006 | EP1648484A1 Formulations for the treatment of arhritis conditions |
| 04/26/2006 | EP1648455A2 Anaplastic lymphoma kinase modulators and methods of use |
| 04/26/2006 | EP1648452A1 2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors |
| 04/26/2006 | EP1648434A1 Ambroxol for treating chronic nociceptive pains |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1414467B1 Topical treatment for mastalgia |
| 04/26/2006 | EP1409485B1 Immunomodulating compounds |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | EP1309592B1 Substituted pyrazoles |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1244702B1 Process for isolation of osteopontin from milk |
| 04/26/2006 | EP1210348B9 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 04/26/2006 | EP1009829B1 Adipocyte-specific protein homologs |
| 04/26/2006 | EP0977562B8 Methods and compositions for delivery of taxanes |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/26/2006 | CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764635A carboxylic acid compounds |
| 04/26/2006 | CN1763101A Antibody of human acidophil chemotactic factor receptor 3 and its preparation method and uses |
| 04/26/2006 | CN1762994A Sulfonyl diphenylethyllene endocompound and its preparation method and pharmaceutical uses |
| 04/26/2006 | CN1762479A Externally applied medicine of stahlianthus involucratus |
| 04/26/2006 | CN1762476A Compound formulation for treating lumbago and preparation process thereof |
| 04/26/2006 | CN1762475A Effervescence tablet for wind-cold type cold |
| 04/26/2006 | CN1762472A Hemiphragma heterophyllum wall wine for injury |
| 04/26/2006 | CN1762469A Externally applied medicine of madeira vine |
| 04/26/2006 | CN1762468A Leatherleaf milletia wine for traumatic injury |
| 04/26/2006 | CN1762464A Externally applied medicine of crescentia cujete L. |